1132935-63-7

基本信息
達(dá)沙布韋
達(dá)塞布韋
達(dá)沙布韋 DASABUVIR
N-(6-(3-(叔丁基)-5-(2,4-二氧代-3,4-二氫嘧啶-1(2H)-基)-2-甲氧基苯基)萘-2-基)甲磺酰胺
ABT-333
Dasabuvir
ABT333
ABT 333
ABT-333/Dasabuvir
Dasabuvir (ABT-333)
N-{6-[5-(2,4-Dioxo-3,4-dihydro-1(2H)-pyrimidinyl)-2-methoxy-3-(2-methyl-2-propanyl)phenyl]-2-naphthyl}methanesulfonamide
Methanesulfonamide, N-[6-[5-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-(1,1-dimethylethyl)-2-methoxyphenyl]-2-naphthalenyl]-
N-[6-[3-tert-Butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl]naphthalen-2-yl]methanesulfonamide Dasabuvir (ABT-333)
物理化學(xué)性質(zhì)
制備方法

1132940-53-4
![N-[6-(4,4,5,5-四甲基-1,3,2-二氧硼雜環(huán)戊烷-2-基)萘-2-基]甲烷磺酰胺](/CAS/GIF/1132940-88-5.gif)
1132940-88-5

1132935-63-7
S3:在氮?dú)獗Wo(hù)下,向反應(yīng)容器中加入1,4-二惡烷(141.4 L)、鈀催化劑Pd(PPh3)4(3.9 kg)和水(70.68 L),隨后加入N-(6-(4,4,5,5-四甲基-1,3,2-二氧雜硼雜環(huán)戊烷-2-基)萘-2-基)甲磺酰胺(23.56 kg)和1-(3-(叔丁基)-5-碘-4-甲氧基苯基)嘧啶-2,4(1H,3H)-二酮(27.13 kg),攪拌混合。接著加入碳酸鈉(8.63 kg),將反應(yīng)溶液保持4-6小時(shí),期間通過TLC監(jiān)測(cè)反應(yīng)進(jìn)度直至反應(yīng)完成。反應(yīng)完成后,將反應(yīng)溶液冷卻至40℃,然后用乙酸乙酯(235.6 L)稀釋。合并的有機(jī)相用水(47.12 L)洗滌,隨后在50℃下減壓蒸餾濃縮有機(jī)相。粗產(chǎn)物中加入乙酸乙酯(94.24 L),在50-60℃下攪拌30分鐘,最終得到粗產(chǎn)物(29.45 kg)。粗產(chǎn)物經(jīng)過抽濾后,通過硅膠柱色譜法進(jìn)行純化。該取代反應(yīng)為單一步驟,產(chǎn)率為76.5%。
參考文獻(xiàn):
[1] Patent: CN107266373, 2017, A. Location in patent: Paragraph 0057; 0058; 0059
[2] Patent: WO2009/39134, 2009, A1. Location in patent: Page/Page column 109
[3] Patent: WO2009/39127, 2009, A1. Location in patent: Page/Page column 168-169
[4] Patent: WO2009/39134, 2009, A1. Location in patent: Page/Page column 102-103; 109